|
Co-existing alterations in cell-cycle pathway genes and impact on benefit from trastuzumab in advanced esophagogastric cancers (EGC): Analysis of 527 Her2-amplified cases. |
|
|
Consulting or Advisory Role - Boston Biomedical; Five Prime Therapeutics; Lilly; Merck |
|
Research Funding - Merck (Inst); Novonco Therapeutics (Inst) |
|
|
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Lilly |
Speakers' Bureau - Foundation Medicine |
Research Funding - Leap Therapeutics (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Agios; Blueprint Medicines; Exelixis |
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I) |
|
|
Employment - Foundation Medicine |
Leadership - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
Patents, Royalties, Other Intellectual Property - Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center |
|
|
Employment - Foundation Medicine |
Leadership - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
Research Funding - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Genmab; Gritstone Bio; Guardant Health; Lilly; Merck; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics |
Speakers' Bureau - Foundation Medicine; Guardant Health |
Research Funding - Genentech; OncoPlex Diagnostics |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |